local_hospital

Assistance Publique Hopitaux De Paris

Address
lock Available on a paid plan

Digestive System Diseases and Biological Phenomena

At Assistance Publique Hopitaux De Paris in Clamart, France, clinical research in Chirurgie Digestive focuses on digestive system diseases, especially colorectal cancer with hepatic metastasis. The studies are aimed at understanding and improving treatment outcomes, with attention to longer-term disease control and patient survival.

  • Research on metastatic colorectal cancer and strategies to improve disease-free survival
  • Clinical evaluation of treatments for digestive system cancers with spread to the liver

This area of work reflects a strong focus on testing whether new or adapted treatment approaches can better manage advanced gastrointestinal cancer and support more effective care.

Biological Phenomena in Reproductive Medicine

Another line of research at this hospital examines biological phenomena linked to assisted reproduction, including IVF and ICSI cycles with embryo transfer planned in the same treatment cycle. The goal is to improve the chances of successful pregnancy by refining ovulation induction and luteal phase support.

  • Studies of in vitro fertilization and intracytoplasmic sperm injection protocols
  • Evaluation of approaches intended to increase live birth rates

These trials are designed to compare treatment strategies and determine whether updated reproductive support methods can lead to better outcomes for patients seeking fertility care.

Site Overview

assignment
3
connected trials
corporate_fare
2
sponsors
science
21
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
3
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 3 therapeutic areas and 15 of 21 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
2
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
3
Outperforms 55% of sites
public
Therapeutic diversity
3areas
Outperforms 59% of sites
groups
Sponsor diversity
2sponsors
Outperforms 45% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Assistance Publique Hopitaux De Paris

lock Showing 1 of 3 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Postoperative Chemotherapy Reintroduction with FOLFIRI and Targeted Therapy in Colorectal Cancer Patients with Hepatic MetastasesAssistance Publique Hopitaux De ParisPhase IIIRecruitingJun 2025

IMP list

lock Showing 1 of 21 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Abiraterone Acetate1Unknown2018-04-092018-04-09

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.